View Post

ICON and Genomics England

Published on Apr 25, 2016 The 100,000 Genomes Project is creating the world’s largest genome sequencing project for cancers and rare diseases, and has the potential to transform the diagnosis and treatment of cancers and rare diseases. As Data Management Partner for this transformative project, ICON is using its world-class capabilities to validate and securely manage the large, complex data …

View Post

Drawn to Science: T-cell bispecific antibodies

Published on May 31, 2016 At Roche Pharma Research and Early Development, we are working on a novel form of engineered antibodies for cancer immunotherapy that we call T-cell bispecific antibodies. We consider them match-makers between T-Cells and cancer cells. With two handles, they recognize specific markers on the surface of cancer cells. A third handle is designed to hook …